Physician profile
Anna Schwartz
NPI 1871590687
$750.68
in general payments reported to CMS, 2019-2025
11 companies · $161 in 2025
The $161 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $82.35 · 2020: $105 · 2021: $69.00 · 2022: $107 · 2023: $93.17 · 2024: $133 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $252.64 | 2019-2025 | Vaxneuvance, Gardasil 9, Vaxelis |
| Glaxosmithkline, LLC. | $225.90 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $95.41 | 2023-2025 | |
| Krystal Biotech INC | $37.27 | 2025 | Vyjuvek |
| Kaleo, INC. | $27.32 | 2022-2024 | Auvi-Q |
| Hologic Sales and Service, LLC | $24.99 | 2023 | Thinprep 2000 Processor |
| Pfizer INC. | $24.79 | 2022 | |
| Cranial Technologies, INC | $19.55 | 2020 | |
| Verrica Pharmaceuticals INC. | $17.97 | 2024 | Ycanth |
| Aytu Biopharma, INC. | $13.69 | 2022 | |
| Neurelis, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.